FeesSafety
Pluang+

CIBC lowers gold price forecasts but remains bullish long-term amid inflation and geopolitical risks.

Market News
20 Oct 2026, 17:32 WIB
Kitco
View Source
Neutral
CIBC lowers gold price forecasts but remains bullish long-term amid inflation and geopolitical risks.

CIBC Capital Markets has reduced its gold price forecasts through 2031, citing challenges from higher bond yields and a strong U.S. dollar driven by inflation and restrictive Fed policies. Despite lowering the 2026-2028 price estimates significantly, the bank remains bullish on gold over the long term due to persistent inflation, geopolitical tensions, government debt concerns, and central bank reserve diversification. Physical gold demand and central bank purchases continue to support prices, while limited mine production growth adds further price stability. CIBC expects a potential price recovery if inflation eases and real interest rates decline in the coming years.

Gold price forecasts by CIBC Capital Markets have been lowered through 2031 due to higher bond yields and a strong U.S. dollar, though a recovery to $5,200 by 2027 is anticipated. For readers following U.S. stocks on Pluang, here is the market snapshot as of Oct 20, 2026 20:51 WIB: out of 150 priced stocks, 88 rose and 60 fell. Notable movers include KEY at USD 20.63 (+3.56%), LI at USD 11.69 (+3.54%) with 100% buy order activity, and ADBE at USD 255.80 (+3.53%).

More News

French firms boost AI-driven cybersecurity, focusing on productivity and operational results over processes.

French firms boost AI-driven cybersecurity, focusing on productivity and operational results over processes.

A new study by Securonix shows French organizations are increasingly adopting AI-driven cybersecurity operations, prioritizing productivity and measurable outcomes rather than just processes. French firms lead in allowing AI to automatically trigger ...

Market News
Neutral
37 minutes ago
Lakefront Biotherapeutics launches new €50M share buyback after completing initial program

Lakefront Biotherapeutics launches new €50M share buyback after completing initial program

Lakefront Biotherapeutics has started a new €50 million share buyback program following the completion of its initial €50 million program, in which it repurchased about 1.99 million shares. The new program, running until March 31, 2027, aims to enhan...

Company Fundamentals
Bullish
2 hours ago
Exosens wins order for 25,000 image intensifier tubes to boost European night vision tech.

Exosens wins order for 25,000 image intensifier tubes to boost European night vision tech.

Exosens secured a firm order to supply 25,000 high-performance 4G+ image intensifier tubes to Theon Sensors for integration into night vision devices, with deliveries starting late 2026. This order is part of a long-term agreement through 2030 and in...

Market News
Bullish
2 hours ago
Exosens secures a major order for 25,000 light intensifier tubes for night vision devices through 2030.

Exosens secures a major order for 25,000 light intensifier tubes for night vision devices through 2030.

Exosens has received a firm order for 25,000 high-performance 4G+ light intensifier tubes to equip night vision products for Theon, under a long-term supply agreement extended through 2030. The order includes options for an additional 35,000 tubes, p...

Market News
Bullish
2 hours ago
Jyske Bank buys back 2.45M shares worth DKK 2.39B, owning 4.22% of its stock by Nov 2026.

Jyske Bank buys back 2.45M shares worth DKK 2.39B, owning 4.22% of its stock by Nov 2026.

Jyske Bank is conducting a share buyback program running from February 5, 2026, to January 29, 2027, with a maximum value of DKK 3 billion. As of mid-November 2026, the bank has repurchased 2,453,745 shares at an average price of DKK 974.50 per share...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App